News

Radiopharmaceutical therapies (RPTs) are transforming cancer treatment by combining radiation with targeted drug delivery. These therapies require a delicate balance between effectiveness and safety, especially considering the unique long-term risks of radiation exposure. The FDA recently released a draft guidance…   Read More

Gliomas are the most common type of malignant primary brain tumor. Imaging is crucial in diagnosing gliomas and evaluating treatment responses. Proper application and customization of the RANO and RAPNO criteria for each unique clinical trial, including criteria clarifications and…   Read More

Imaging is vital for diagnosing, staging, and monitoring multiple myeloma (MM) in clinical trials. Common imaging methods include Whole-Body Low-Dose CT, ideal for initial MM-related lytic bone lesion assessment; MRI, the gold standard for detecting bone marrow involvement; and 18F-FDG…   Read More

Colorectal cancer (CRC) is the third most frequent cancer diagnosed in the world, and the second most frequent cause of death related to cancer. Imaging has a critical role in diagnosis, determining stage of the disease, selecting treatment strategies, and…   Read More

Medical imaging is pivotal in clinical trials for gastric cancer, where precise staging and response evaluation are essential. Imaging technologies like CT, MRI, and PET are integrated into clinical trials, typically using Response Evaluation Criteria in Solid Tumors (RECIST). These…   Read More

The assessment of peritoneal metastasis in ovarian cancer is a critical challenge in clinical trials. Inaccurate evaluations can lead to significant discrepancies in treatment responses and patient management. Recent discussions, including insights from Dr. M. Sharma and colleagues at ECR25,…   Read More

In the rapidly evolving landscape of clinical trials, maintaining data integrity and minimizing bias while performing BICR (Blinded Independent Central Review) is paramount. The automation of reviewer performance monitoring through advanced platforms, complemented by artificial intelligence (AI), is revolutionizing the…   Read More

Prostate cancer is a significant health concern for men, being the most prevalent non-dermatologic cancer and the second leading cause of cancer-related deaths. Advances in imaging, particularly positron emission tomography (PET), along with radioligand therapy (RLT) using specific tracers, are…   Read More

Imaging plays a crucial role in pancreatic cancer clinical trials, particularly in the early diagnosis, monitoring, and treatment response evaluation. Often referred to as the "Silent Killer," it is a highly aggressive malignancy that often presents asymptomatically in its early…   Read More

Cervical cancer is a significant global health challenge, with over half a million new cases diagnosed annually. Ranking as the fourth most common cancer among women worldwide, its early detection and accurate staging are crucial. Magnetic resonance imaging (MRI) plays…   Read More